{"id":171138,"date":"2023-02-16T17:27:37","date_gmt":"2023-02-16T17:27:37","guid":{"rendered":"https:\/\/precoinnews.com\/?p=171138"},"modified":"2023-02-16T17:27:37","modified_gmt":"2023-02-16T17:27:37","slug":"natera-rallies-as-medicare-extends-coverage-of-signatera-test-for-breast-cancer","status":"publish","type":"post","link":"https:\/\/precoinnews.com\/bitcoin\/natera-rallies-as-medicare-extends-coverage-of-signatera-test-for-breast-cancer\/","title":{"rendered":"Natera Rallies As Medicare Extends Coverage Of Signatera Test For Breast Cancer"},"content":{"rendered":"
Shares of diagnostics company, Natera, Inc. (NTRA) are rising more than 15% Thursday morning at $49.03.<\/p>\n
The company today said it received confirmation about Medicare extending coverage for Natera’s Signatera test for breast cancer.<\/p>\n
The coverage will include serial monitoring in all subtypes, including hormone receptor-positive, HER2-positive, and triple negative breast cancers, the company said.<\/p>\n
NTRA has traded in the range of $26.10-$71.00 in the last 1 year. <\/p>\n